Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net premium income has been realized | 0.16%55.96B | 3.52%111.27B | 3.23%55.87B | -1.30%107.49B | -3.57%54.13B | -56.52%108.91B | -61.73%56.14B | 14.94%250.5B | 14.71%146.67B | 4.39%217.93B |
| -Net premium income | 0.16%55.96B | 3.52%111.27B | 3.23%55.87B | -1.30%107.49B | -3.57%54.13B | -56.73%108.91B | -62.59%56.14B | 14.24%251.71B | 15.24%150.04B | 3.76%220.33B |
| -Including:Total premium income | 0.16%55.96B | 3.52%111.27B | 3.23%55.87B | -1.30%107.49B | -3.57%54.13B | -58.52%108.91B | -64.24%56.14B | 12.42%262.55B | 14.52%156.97B | 4.72%233.53B |
| -Including: Premium | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 17.92%-10.84B | -0.74%-6.93B | -23.78%-13.2B |
| -Unearned premium reserve | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 49.27%-1.22B | -44.22%-3.37B | 33.02%-2.4B |
| Investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 24.23%58.23B | 53.61%32.37B | 51.81%46.87B |
| Special items of income | -40.10%24.13B | 69.53%69.86B | 52.71%40.28B | 93.96%41.21B | 64.85%26.38B | 197.77%21.24B | 371.61%16B | 34.35%7.13B | 46.17%3.39B | 8.73%5.31B |
| Total income | -16.70%80.09B | 21.81%181.13B | 19.44%96.16B | 14.25%148.7B | 11.60%80.51B | -58.79%130.15B | -60.46%72.14B | 16.94%315.86B | 20.62%182.43B | 10.46%270.11B |
| Insurance business expenses and other expenses | 11.76%-69.6B | -18.85%-158.21B | -9.26%-78.87B | -10.07%-133.11B | -13.08%-72.19B | 60.11%-120.94B | 63.24%-63.84B | -19.79%-303.17B | -22.52%-173.69B | -9.74%-253.09B |
| -Commission and handling fee expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -14.00%-24.11B | -19.29%-13.97B | 11.91%-21.15B |
| -Special items of operating payout | 11.23%-5.35B | -0.27%-11.13B | -10.11%-6.02B | -4.24%-11.1B | -3.24%-5.47B | 96.19%-10.65B | 96.68%-5.3B | -20.32%-279.06B | -22.81%-159.72B | -12.25%-231.94B |
| Total payment、 claims and expenses | 11.76%-69.6B | -18.85%-158.21B | -9.26%-78.87B | -10.07%-133.11B | -13.08%-72.19B | 60.11%-120.94B | 63.24%-63.84B | -19.79%-303.17B | -22.52%-173.69B | -9.74%-253.09B |
| Operating profit | -39.27%10.5B | 47.07%22.92B | 107.80%17.28B | 69.16%15.58B | 0.27%8.32B | -27.38%9.21B | -5.18%8.3B | -25.49%12.69B | -7.78%8.75B | 22.55%17.03B |
| Financial expenses - before tax | 31.17%-1.3B | 8.14%-3.46B | -10.41%-1.9B | -20.50%-3.76B | -10.97%-1.72B | -31.15%-3.12B | -40.73%-1.55B | -8.73%-2.38B | 8.21%-1.1B | 5.93%-2.19B |
| Attributable share of joint ventures and joint ventures | -6.09%1.07B | 1,737.93%2.66B | -8.34%1.14B | -760.49%-162.69M | 285.48%1.24B | -95.96%24.63M | 317.14%322.66M | 138.79%609.43M | 105.35%77.35M | -189.23%-1.57B |
| Earning before tax | -37.91%10.26B | 89.81%22.13B | 110.70%16.53B | 90.68%11.66B | 10.94%7.84B | -43.98%6.11B | -8.48%7.07B | -17.72%10.91B | 12.90%7.73B | -0.46%13.26B |
| Tax | 85.82%-1.07B | -575.53%-9.33B | -2,235.90%-7.55B | -161.57%-1.38B | -93.91%-323.21M | 5,720.60%2.24B | 74.45%-166.68M | 101.37%38.54M | 63.04%-652.37M | -258.64%-2.81B |
| After-tax profit from continuing operations | 2.38%9.19B | 24.53%12.8B | 19.37%8.98B | 22.98%10.28B | 8.93%7.52B | -23.70%8.36B | -2.40%6.9B | 4.74%10.95B | 39.29%7.07B | -16.63%10.46B |
| Earning After tax | 2.38%9.19B | 24.53%12.8B | 19.37%8.98B | 22.98%10.28B | 8.93%7.52B | -23.70%8.36B | -2.40%6.9B | 4.74%10.95B | 39.29%7.07B | -16.63%10.46B |
| Minority profit | -17.76%2.43B | 6.83%4.37B | 28.28%2.95B | 0.67%4.09B | -10.54%2.3B | 18.07%4.06B | 31.11%2.57B | -12.01%3.44B | -10.92%1.96B | 10.57%3.91B |
| Profits attributable to shareholders | 12.24%6.76B | 36.22%8.43B | 15.45%6.03B | 44.05%6.19B | 20.49%5.22B | -42.81%4.3B | -15.26%4.33B | 14.73%7.51B | 77.74%5.11B | -27.30%6.55B |
| Basic earnings per share | 13.39%1.744 | 38.33%2.068 | 12.67%1.538 | 25.00%1.495 | 13.28%1.365 | -42.80%1.196 | -15.32%1.205 | 14.76%2.091 | 77.88%1.423 | -25.84%1.822 |
| Diluted earnings per share | 13.39%1.744 | 38.33%2.068 | 12.67%1.538 | 25.00%1.495 | 13.28%1.365 | -42.80%1.196 | -15.32%1.205 | 14.76%2.091 | 77.88%1.423 | -25.84%1.822 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | PricewaterhouseCoopers | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.